Insider Buying: Amarillo Biosciences Inc. (AMAR) CEO Acquires 203,000 Shares of Stock

Amarillo Biosciences Inc. (OTCMKTS:AMAR) CEO Stephen T. Chen acquired 203,000 shares of the business’s stock in a transaction that occurred on Monday, November 13th. The shares were purchased at an average price of $0.19 per share, with a total value of $38,570.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Amarillo Biosciences Inc. (OTCMKTS:AMAR) traded up $0.02 during midday trading on Tuesday, reaching $0.25. The company’s stock had a trading volume of 3,189 shares, compared to its average volume of 2,656. Amarillo Biosciences Inc. has a one year low of $0.15 and a one year high of $0.30.

COPYRIGHT VIOLATION NOTICE: This report was published by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright legislation. The legal version of this report can be read at https://transcriptdaily.com/2017/11/14/insider-buying-amarillo-biosciences-inc-amar-ceo-acquires-203000-shares-of-stock.html.

About Amarillo Biosciences

Amarillo Biosciences, Inc is engaged in the business of biopharmaceutical research and development. The Company develops biologics for the treatment of human and animal diseases. The Company’s focus is research aimed at the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia and other indications using natural human interferon alpha that is administered in a low dose oral form.

Insider Buying and Selling by Quarter for Amarillo Biosciences (OTCMKTS:AMAR)

Receive News & Ratings for Amarillo Biosciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amarillo Biosciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply